News you can use: health & drug safety updates

2016

  • December 13, 2016

    A new analysis reveals that 1 in 6 U.S. adults reported taking psychiatric drugs at least once in 2013. Researchers from the Institute for Safe Medication Practices and Risk Sciences International used the 2013 Medical Expenditure Panel Survey to calculate percentages of the adult population using three classes of psychiatric drugs: antidepressants; anxiolytics, sedatives, and hypnotics; and antipsychotics.

  • December 9, 2016

    A recent study investigated dosages of high-risk medications administered to older adults who fall while hospitalized and sought to determine whether electronic default doses are appropriate for older individuals. In their retrospective study, researchers from the Icahn School of Medicine at Mount Sinai and the New York University School of Medicine found that 62% of 328 falls occurred in individuals who had received at least one high-risk medication within the 24 hours before the fall. They note that 16% of those patients received at least two high-risk drugs in that period, while

  • December 1, 2016

    NCPIE serves as co-editor for a monthly column in Pharmacy Today (American Pharmacists Association) The column is entitled “One-to-One” and is intended to help develop pharmacists’ medication communication and counseling skills to promote safe and appropriate medicine use.

  • November 30, 2016

    If your medicine has expired, it may not provide the treatment you need. In this Consumer Update video, FDA Pharmacist Ilisa Bernstein explains how expiration dates help determine if medicine is safe to use and will work as intended. Related: Safe Medicine Disposal

  • November 28, 2016

    Providers can better detect prescribing mistakes through strong patient engagement and education, ultimately boosting medication safety, new research from the Office of the National Coordinator for Health Information Technology (ONC) shows. The report, which focuses on medication ordering within the electronic health record (EHR), first recommended that clinicians provide patients with after-visit summaries, including detailed medication lists.

  • November 17, 2016

    "Content below from: “Don’t leave parents to their own measuring devices,” Pharmacy Today, APhA, November 2016, Volume 22, Issue 11, Page 31)

  • November 17, 2016

    The U.S. Surgeon General has issued a new report that says one in seven Americans will face substance addictions and only 10% of those who are now addicted receive treatment. The study, Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health, is the first report from a U.S. surgeon general on substance abuse.

  • November 16, 2016
    Research Design: Two community pharmacies serving an ethnically diverse population in the Pacific Northwest. Participants were consented patients with antihypertension prescriptions who screened positive for low health literacy based on the Test of Functional Health Literacy Short Form. Participants in the intervention arm received antihypertensive medications and recordings of pharmacists' counseling in Talking Pill Bottles at baseline. Control arm participants received antihypertensive medications and usual care instructions. Main outcome measures Results
  • November 1, 2016
    About 70%of US adults, ages 65 or older, have high blood pressure. About 50% of adults ages 65 or older with high blood pressure don’t have it under control. About 5 million adults, ages 65 or older, with Medicare Part D aren’t taking their blood pressure medicine as directed. High blood pressure can lead to heart disease, stroke, kidney disease, and death. About 70% of US adults age 65 or older have high blood pressure and only about half have it under control (less than 140/90 mmHg). Blood pressure
  • November 1, 2016

    Patients will likely be introduced to biosimilars as cheaper versions of the biologic drugs—and they may assume the new products are “generics.” But while biosimilars are as clinically effective as the brand-name product and cost less, biosimilars are not exact replicas. As patients get accustomed to biosimilars, they will rely on their pharmacists’ knowledge.

Pages